Immunology and Cell Biology, ISSN 0818-9641, 02/2007, Volume 85, Issue 2, pp. 138 - 147
Experimental visceral leishmaniasis (VL) caused by infection with Leishmania donovani results in the development of organ‐specific immunity in the two main...
pathology | liver | spleen | Leishmania | granuloma | Spleen | Granuloma | Pathology | Liver | SLC11A1 FORMERLY NRAMP1 | HUMAN DENDRITIC CELLS | TGF-BETA | T-CELL | DISTINCT ROLES | IMMUNOLOGY | DONOVANI INFECTION | CELL BIOLOGY | TUMOR-NECROSIS-FACTOR | INTERFERON-GAMMA | RESISTANCE GENE LSH | IN-VIVO | Liver Cirrhosis - immunology | Spleen - immunology | Humans | Immunity, Innate - genetics | Leishmaniasis, Visceral - immunology | Liver - immunology | Macrophages - immunology | Disease Models, Animal | Macrophages - physiology | Leishmania infantum - pathogenicity | Leishmania donovani - immunology | Gene Expression Regulation - immunology | Leishmania donovani - pathogenicity | Dendritic Cells, Follicular - physiology | Chemokines - genetics | Leishmaniasis, Visceral - metabolism | Leishmaniasis, Visceral - pathology | Animals | Dendritic Cells, Follicular - immunology | Models, Biological | Leishmaniasis, Visceral - genetics | Leishmania infantum - immunology | Granuloma - immunology | Chemokines - metabolism | Mice | Leishmania infantum, pathogenicity | Macrophages, immunology | Leishmaniasis, Visceral, immunology | Macrophages, physiology | Chemokines, metabolism | Leishmaniasis, Visceral, pathology | Gene Expression Regulation, immunology | Leishmania donovani, immunology | Spleen, immunology | Granuloma, immunology | Leishmania donovani, pathogenicity | Chemokines, genetics | Leishmaniasis, Visceral, genetics | Liver, immunology | Immunity, Natural, genetics | Dendritic Cells, Follicular, physiology | Liver Cirrhosis, immunology | Leishmania infantum, immunology | Dendritic Cells, Follicular, immunology | Leishmaniasis, Visceral, metabolism
pathology | liver | spleen | Leishmania | granuloma | Spleen | Granuloma | Pathology | Liver | SLC11A1 FORMERLY NRAMP1 | HUMAN DENDRITIC CELLS | TGF-BETA | T-CELL | DISTINCT ROLES | IMMUNOLOGY | DONOVANI INFECTION | CELL BIOLOGY | TUMOR-NECROSIS-FACTOR | INTERFERON-GAMMA | RESISTANCE GENE LSH | IN-VIVO | Liver Cirrhosis - immunology | Spleen - immunology | Humans | Immunity, Innate - genetics | Leishmaniasis, Visceral - immunology | Liver - immunology | Macrophages - immunology | Disease Models, Animal | Macrophages - physiology | Leishmania infantum - pathogenicity | Leishmania donovani - immunology | Gene Expression Regulation - immunology | Leishmania donovani - pathogenicity | Dendritic Cells, Follicular - physiology | Chemokines - genetics | Leishmaniasis, Visceral - metabolism | Leishmaniasis, Visceral - pathology | Animals | Dendritic Cells, Follicular - immunology | Models, Biological | Leishmaniasis, Visceral - genetics | Leishmania infantum - immunology | Granuloma - immunology | Chemokines - metabolism | Mice | Leishmania infantum, pathogenicity | Macrophages, immunology | Leishmaniasis, Visceral, immunology | Macrophages, physiology | Chemokines, metabolism | Leishmaniasis, Visceral, pathology | Gene Expression Regulation, immunology | Leishmania donovani, immunology | Spleen, immunology | Granuloma, immunology | Leishmania donovani, pathogenicity | Chemokines, genetics | Leishmaniasis, Visceral, genetics | Liver, immunology | Immunity, Natural, genetics | Dendritic Cells, Follicular, physiology | Liver Cirrhosis, immunology | Leishmania infantum, immunology | Dendritic Cells, Follicular, immunology | Leishmaniasis, Visceral, metabolism
Journal Article
Parasites and Vectors, ISSN 1756-3305, 03/2016, Volume 9, Issue 1, p. 118
Unicellular eukaryotes of the genus Leishmania are collectively responsible for a heterogeneous group of diseases known as leishmaniasis. The visceral form of...
INTRACELLULAR PATHOGEN | TUMOR-NECROSIS-FACTOR | INDIAN KALA-AZAR | HUMAN CUTANEOUS LEISHMANIASIS | FC-GAMMA RECEPTORS | DENDRITIC CELLS | INTERFERON-GAMMA | IFN-GAMMA | T-CELL EXHAUSTION | DONOVANI INFECTION | PARASITOLOGY | Adaptive Immunity | Liver - pathology | Spleen - immunology | Humans | Leishmaniasis, Visceral - immunology | Immunity, Innate | Leishmania - immunology | Leishmaniasis, Visceral - pathology | Host-Pathogen Interactions | Spleen - parasitology | Liver - immunology | Animals | Immunity, Humoral | Leishmania - physiology | Leishmaniasis, Visceral - parasitology | Liver - parasitology | Spleen - pathology | Immunity, Cellular | Immune response | Cytokines | Host-parasite relationships | Development and progression | Genetic aspects | Regulation | Leishmaniasis | Properties
INTRACELLULAR PATHOGEN | TUMOR-NECROSIS-FACTOR | INDIAN KALA-AZAR | HUMAN CUTANEOUS LEISHMANIASIS | FC-GAMMA RECEPTORS | DENDRITIC CELLS | INTERFERON-GAMMA | IFN-GAMMA | T-CELL EXHAUSTION | DONOVANI INFECTION | PARASITOLOGY | Adaptive Immunity | Liver - pathology | Spleen - immunology | Humans | Leishmaniasis, Visceral - immunology | Immunity, Innate | Leishmania - immunology | Leishmaniasis, Visceral - pathology | Host-Pathogen Interactions | Spleen - parasitology | Liver - immunology | Animals | Immunity, Humoral | Leishmania - physiology | Leishmaniasis, Visceral - parasitology | Liver - parasitology | Spleen - pathology | Immunity, Cellular | Immune response | Cytokines | Host-parasite relationships | Development and progression | Genetic aspects | Regulation | Leishmaniasis | Properties
Journal Article
PLoS Pathogens, ISSN 1553-7366, 01/2013, Volume 9, Issue 1, p. e1003053
Leishmaniasis is a vector-borne neglected tropical disease associated with a spectrum of clinical manifestations, ranging from self-healing cutaneous lesions...
IMMUNE-RESPONSE | SAND FLY VECTOR | HAMSTER MODEL | AMASTIGOTE-SPECIFIC PROTEIN | LUTZOMYIA-LONGIPALPIS | MICROBIOLOGY | DELAYED-TYPE HYPERSENSITIVITY | CUTANEOUS LEISHMANIASIS | VIROLOGY | FUNCTIONAL-EVALUATION | IN-VIVO | GENE-EXPRESSION | PARASITOLOGY | Leishmania donovani - immunology | Humans | Leishmaniasis, Cutaneous - pathology | Leishmania donovani - pathogenicity | Leishmaniasis, Visceral - immunology | Neglected Diseases | Leishmaniasis, Cutaneous - immunology | Leishmaniasis, Visceral - pathology | Host-Pathogen Interactions | Macrophages - parasitology | Animals | Leishmaniasis, Cutaneous - parasitology | Leishmania donovani - genetics | Leishmaniasis, Visceral - parasitology | Disease Vectors | Psychodidae - parasitology | Kala-azar | Viral genetics | Physiological aspects | Development and progression | Genetic aspects | Virulence (Microbiology) | Research | Proteins | Medical research | Infections | Parasites | Rodents | Tropical diseases
IMMUNE-RESPONSE | SAND FLY VECTOR | HAMSTER MODEL | AMASTIGOTE-SPECIFIC PROTEIN | LUTZOMYIA-LONGIPALPIS | MICROBIOLOGY | DELAYED-TYPE HYPERSENSITIVITY | CUTANEOUS LEISHMANIASIS | VIROLOGY | FUNCTIONAL-EVALUATION | IN-VIVO | GENE-EXPRESSION | PARASITOLOGY | Leishmania donovani - immunology | Humans | Leishmaniasis, Cutaneous - pathology | Leishmania donovani - pathogenicity | Leishmaniasis, Visceral - immunology | Neglected Diseases | Leishmaniasis, Cutaneous - immunology | Leishmaniasis, Visceral - pathology | Host-Pathogen Interactions | Macrophages - parasitology | Animals | Leishmaniasis, Cutaneous - parasitology | Leishmania donovani - genetics | Leishmaniasis, Visceral - parasitology | Disease Vectors | Psychodidae - parasitology | Kala-azar | Viral genetics | Physiological aspects | Development and progression | Genetic aspects | Virulence (Microbiology) | Research | Proteins | Medical research | Infections | Parasites | Rodents | Tropical diseases
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 04/2014, Volume 20, Issue 4, pp. 286 - 299
Leishmaniasis is a vector-born chronic infectious disease caused by a group of protozoan parasites of the genus . Whereas most immunocompetent individuals will...
immunosuppression | transplant | visceral | HIV | leishmaniasis | Anti-TNF-a | Anti‐TNF‐α | Visceral | Immunosuppression | Leishmaniasis | Anti-TNF-α | Transplant | LIVER-TRANSPLANT RECIPIENTS | LATEX AGGLUTINATION-TEST | INFECTIOUS DISEASES | MICROBIOLOGY | HIV-INFECTED PATIENTS | LIPOSOMAL AMPHOTERICIN-B | REAL-TIME PCR | AZAR DERMAL LEISHMANIASIS | ACTIVE ANTIRETROVIRAL THERAPY | Anti-TNF-alpha | OF-THE-LITERATURE | NECROSIS FACTOR THERAPY | VISCERAL LEISHMANIASIS | Recurrence | Global Health | Leishmaniasis, Cutaneous - diagnosis | Humans | Leishmaniasis, Cutaneous - pathology | Treatment Outcome | Leishmaniasis, Cutaneous - drug therapy | Leishmaniasis, Visceral - pathology | Leishmaniasis, Visceral - drug therapy | Leishmaniasis, Cutaneous - epidemiology | Immunocompromised Host | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Leishmaniasis, Visceral - epidemiology | Leishmaniasis, Visceral - diagnosis | Development and progression | Immunotherapy
immunosuppression | transplant | visceral | HIV | leishmaniasis | Anti-TNF-a | Anti‐TNF‐α | Visceral | Immunosuppression | Leishmaniasis | Anti-TNF-α | Transplant | LIVER-TRANSPLANT RECIPIENTS | LATEX AGGLUTINATION-TEST | INFECTIOUS DISEASES | MICROBIOLOGY | HIV-INFECTED PATIENTS | LIPOSOMAL AMPHOTERICIN-B | REAL-TIME PCR | AZAR DERMAL LEISHMANIASIS | ACTIVE ANTIRETROVIRAL THERAPY | Anti-TNF-alpha | OF-THE-LITERATURE | NECROSIS FACTOR THERAPY | VISCERAL LEISHMANIASIS | Recurrence | Global Health | Leishmaniasis, Cutaneous - diagnosis | Humans | Leishmaniasis, Cutaneous - pathology | Treatment Outcome | Leishmaniasis, Cutaneous - drug therapy | Leishmaniasis, Visceral - pathology | Leishmaniasis, Visceral - drug therapy | Leishmaniasis, Cutaneous - epidemiology | Immunocompromised Host | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Leishmaniasis, Visceral - epidemiology | Leishmaniasis, Visceral - diagnosis | Development and progression | Immunotherapy
Journal Article
5.
Full Text
Visceral leishmaniasis presenting with pancytopenia and circulating blastlike lymphocytes
Blood, ISSN 0006-4971, 06/2018, Volume 131, Issue 25, pp. 2867 - 2867
HEMATOLOGY | Leishmaniasis, Visceral - blood | Pancytopenia - pathology | Humans | Lymphocytes - parasitology | Child, Preschool | Male | Leishmaniasis, Visceral - pathology | Bone Marrow - parasitology | Lymphocytes - pathology | Pancytopenia - complications | Bone Marrow - pathology | Leishmaniasis, Visceral - complications | Leishmania donovani - isolation & purification | Pancytopenia - parasitology | Leishmaniasis, Visceral - parasitology | Pancytopenia - blood
Journal Article
Blood, ISSN 0006-4971, 08/2017, Volume 130, Issue 5, pp. 692 - 692
HEMATOLOGY | Leishmaniasis, Visceral - blood | Diagnosis, Differential | Parasitemia - diagnosis | Humans | Male | Leishmaniasis, Visceral - pathology | Parasitemia - pathology | Bone Marrow - pathology | HIV Infections - complications | Adult | Leishmania donovani - isolation & purification | Monocytes - parasitology | Histiocytes - parasitology | Leishmaniasis, Visceral - diagnosis
Journal Article
Medicine, ISSN 0025-7974, 09/2018, Volume 97, Issue 38, p. e12410
Rationale: T-cell prolymphocytic leukaemia (T-PLL) is a rare aggressive lymphoid disease featured by a significant increased lymphocyte count and obvious...
MEDICINE, GENERAL & INTERNAL | diagnosis | T-cell prolymphocytic leukemia | morphology | visceral leishmaniasis | immunophenotype | Leishmaniasis, Visceral - blood | Humans | Middle Aged | Male | Leishmaniasis, Visceral - pathology | Leishmaniasis, Visceral - drug therapy | Leukemia, Prolymphocytic, T-Cell - pathology | Leukemia, Prolymphocytic, T-Cell - blood | Fatal Outcome | Splenomegaly - etiology | Amphotericin B - administration & dosage | Immunophenotyping - methods | Leishmania donovani - isolation & purification | Leishmaniasis, Visceral - parasitology | Leukemia, Prolymphocytic, T-Cell - therapy | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Leukemia, Prolymphocytic, T-Cell - complications | Hepatomegaly - etiology | Kala-azar | Prognosis | Drug therapy | Leukemia
MEDICINE, GENERAL & INTERNAL | diagnosis | T-cell prolymphocytic leukemia | morphology | visceral leishmaniasis | immunophenotype | Leishmaniasis, Visceral - blood | Humans | Middle Aged | Male | Leishmaniasis, Visceral - pathology | Leishmaniasis, Visceral - drug therapy | Leukemia, Prolymphocytic, T-Cell - pathology | Leukemia, Prolymphocytic, T-Cell - blood | Fatal Outcome | Splenomegaly - etiology | Amphotericin B - administration & dosage | Immunophenotyping - methods | Leishmania donovani - isolation & purification | Leishmaniasis, Visceral - parasitology | Leukemia, Prolymphocytic, T-Cell - therapy | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Leukemia, Prolymphocytic, T-Cell - complications | Hepatomegaly - etiology | Kala-azar | Prognosis | Drug therapy | Leukemia
Journal Article
Blood, ISSN 0006-4971, 01/2016, Volume 127, Issue 4, pp. 513 - 513
HEMATOLOGY | Glucocorticoids - therapeutic use | Lymphohistiocytosis, Hemophagocytic - pathology | Leishmania donovani - drug effects | Lymphohistiocytosis, Hemophagocytic - drug therapy | Humans | Lymphohistiocytosis, Hemophagocytic - diagnosis | Male | Leishmaniasis, Visceral - pathology | Leishmaniasis, Visceral - drug therapy | Lymphohistiocytosis, Hemophagocytic - complications | Antiparasitic Agents - therapeutic use | Bone Marrow - parasitology | Dexamethasone - therapeutic use | Bone Marrow - pathology | Adolescent | Leishmaniasis, Visceral - complications | Leishmania donovani - isolation & purification | Amphotericin B - therapeutic use | Bone Marrow - drug effects | Leishmaniasis, Visceral - diagnosis
Journal Article
Journal of Infection, ISSN 0163-4453, 2015, Volume 71, Issue 2, pp. 271 - 273
Infectious Disease | Purpura | Cryoglobulinemia | Leishmaniasis | INFECTIOUS DISEASES | Cryoglobulinemia - pathology | Humans | Aged, 80 and over | Cryoglobulinemia - diagnosis | Leishmaniasis, Visceral - complications | Male | Purpura - pathology | Leishmaniasis, Visceral - pathology | Purpura - diagnosis
Journal Article